Cargando…
Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product
PURPOSE: Filgrastim, a recombinant human granulocyte-colony stimulating factor, is widely used to treat congenital and acquired neutropenia. Following patent expiration of the innovator filgrastim product, biosimilar filgrastim products have been approved in the EU and shown to be comparable with th...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182392/ https://www.ncbi.nlm.nih.gov/pubmed/30280277 http://dx.doi.org/10.1007/s11095-018-2491-5 |